Literature DB >> 35278

Approach to drug therapy for hypertension.

O G Kuchel, W A Mahon, J K McKenzie, R I Ogilvie.   

Abstract

Prevention of complications of hypertension requires the lowering of blood pressure. The therapeutic goal is to achieve and maintain a diastolic pressure of less than 90 mm Hg with minimal adverse effects. The treatment of patients with established diastolic blood pressures between 90 and 104 mm Hg (determined from three separate readings) should be individualized; general measures such as weight loss and salt restriction should be tried first as an alternative to drug therapy. Patients with diastolic pressure in excess of 104 mm Hg should be treated with antihypertensive drugs; the first step should be the use of a thiazide diuretic in addition to general measures. Patients with diastolic pressures of 90 to 115 mm Hg may require the addition of a beta-adrenergic-receptor antagonist, methyldopa or clonidine if the therapeutic goal is not achieved; rarely they require the further addition of hydralazine or prazosin. Patients with diastolic pressures of 116 to 129 mm Hg usually require initially both a thiazide diuretic and a beta-blocker, methyldopa or clonidine; if the therapeutic goal is not achieved, hydralazine or prazosin is added, and if a further hypotensive effect is required guanethidine can be added. Patients with severe hypertension (diastolic pressures greater than 130 mm Hg) may require urgent treatment with combinations of drugs of all three levels. Emphasis should be placed on individualized therapy and patient compliance in the assessment of therapeutic failures. These "step-care" guidlines represent a framework for antihypertensive therapy devised from information available in 1977. It is not a rigid scheme and should be adjusted to the individual patient to ensure as normal a life as possible.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35278      PMCID: PMC1818933     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Diseases of the cardiovascular system Hypertension--II.

Authors:  J C Petrie
Journal:  Br Med J       Date:  1976-08-07

2.  Hypertension: therapy as recommended by the national committees.

Authors:  J H Moyers
Journal:  Angiology       Date:  1976-02       Impact factor: 3.619

3.  Propranolol in the treatment of hypertension.

Authors:  O B Holland; N M Kaplan
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

4.  Adverse reactions and interactions limiting the use of antihypertensive drugs.

Authors:  A S Nies
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

5.  Drugs in the management of hypertension. Part II.

Authors:  L B Page; H M Yager; J J Sidd
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

Review 6.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 7.  Correlation of pathophysiology and pharmacotherapy in primary hypertension.

Authors:  J Koch-Weser
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

Review 8.  Medical management of primary hypertension . 3.

Authors:  L B Page; J J Sidd
Journal:  N Engl J Med       Date:  1972-11-23       Impact factor: 91.245

9.  Antihypertensive pharmacotherapy.

Authors:  A H Hayes; D W Schneck
Journal:  Postgrad Med       Date:  1976-05       Impact factor: 3.840

10.  Managing hypertension: the postgraduate medicine lecture.

Authors:  R W Gifford
Journal:  Postgrad Med       Date:  1977-03       Impact factor: 3.840

  10 in total
  1 in total

Review 1.  Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

Authors:  M G Myers; S G Carruthers; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.